More than half of women diagnosed with breast cancer undergo breast-conserving surgery with a partial mastectomy. A new study from the Yale Cancer Center found that removing more tissue during this procedure could spare thousands of these patients from a second surgery.
More than half of women diagnosed with breast cancer undergo breast-conserving surgery with a partial mastectomy. A new study from the Yale Cancer Center found that removing more tissue during this procedure could spare thousands of these patients from a second surgery.
Somewhere between 20% and 40% of patients undergoing the procedure have cancer cells at the edge of what was removed, and the presence of these cells, or “positive margins,” often leads to a second surgery.
The researchers studied 235 patients with breast ranging from stage 0 to stage 3 with surgeons performing a partial mastectomy as usual. Patients were randomized in the operating room to either have additional tissue removed around the tumor site or not.
“Despite their best efforts, surgeons could not predict where the cancer was close to the edge,” the study’s lead author, Anees Chagpar, MD, MSc, MA, MPH, MBA, FRCS(C), FACS, associate professor of surgery (oncology) at Yale School of Medicine and director of The Breast Center at Smilow Cancer Hospital at Yale-New Haven, said in a statement. “Taking cavity shave margins cut the positive margin rate in half, without compromising cosmetic outcome or increasing complication rates.”
Patients in the study will be followed for 5 years to evaluate the impact of the technique on recurrence rates.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Study Highlights Key RA-ILD Risk Factors, Urges Early Screening
November 20th 2024This recent study highlights key risk factors for rheumatoid arthritis–associated interstitial lung disease (RA-ILD), emphasizing the importance of early screening to improve diagnosis and patient outcomes.
Read More